Could a new daily pill help young children with ADHD?

NCT ID NCT07717879

Recruiting now Disease control Sponsor: Axsome Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This phase 3 trial tests whether solriamfetol, taken once daily, can reduce ADHD symptoms in children aged 6 to under 12. Over 6 weeks, researchers compare the drug against a placebo using a standard rating scale. The goal is to see if solriamfetol is a safe and effective treatment option for this age group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: solriamfetol capsules taken once daily
What this could lead to: If successful, this could provide a new daily medication option for managing ADHD symptoms in young children.
What could go wrong: This is a short 6-week trial, so long-term safety and effectiveness are not yet known. The drug may not work better than placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADHD

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Clinical Research Site
RECRUITING

Dothan, Alabama, 36303, United States
Clinical Research Site
RECRUITING

Little Rock, Arkansas, 72211, United States
Clinical Research Site
RECRUITING

Coral Gables, Florida, 33146, United States
Clinical Research Site
RECRUITING

Jacksonville, Florida, 32256, United States
Clinical Research Site
RECRUITING

Maitland, Florida, 32751, United States
Clinical Research Site
RECRUITING

Orlando, Florida, 32801, United States
Clinical Research Site
RECRUITING

Bardstown, Kentucky, 40004, United States
Clinical Research Site
RECRUITING

Memphis, Tennessee, 38119, United States
Clinical Research Site
RECRUITING

Austin, Texas, 78759, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.